Nissui Pharmaceutical Co., Ltd. announced consolidated earnings results for the first quarter ended June 30, 2019. For the quarter, the company reported Net Sales were $2,835 million against $2,864 million a year ago. Operating profit was $168 million against $241 million a year ago. Ordinary profit was $170 million against $261 million a year ago. Loss attributable to owners of parent was $1 million against profit attributable to owners of parent of $199 million a year ago. Basic loss per share was $0.06 against basic earnings per share of $8.9 a year ago.

The company provides earnings forecast for the Six months ended ending September 30, 2019. The company forecast net sales of ¥6,400 million. Operating profit of ¥430 million. Ordinary profit of ¥470 million. Profit attributable to owners of parent of ¥334 million. Basic earnings per share of ¥14.91.

The company provides earnings forecast for the year ending March 31, 2020. The company forecast net sales of ¥13,300 million. Operating profit of ¥1,330 million. Ordinary profit of ¥1,420 million. Profit attributable to owners of parent of ¥1,014 million. Basic earnings per share of ¥45.28.

The company provides dividend forecast for the Second quarter of fiscal year ending March 31, 2020. For the Second quarter, company forecast dividend of ¥20 per share.

The company provides dividend forecast for Fiscal year ending March 31, 2020. For the fourth quarter, company forecast dividend of ¥20 per share.